ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Jing Xie
Matched on ORCID iD 0000-0001-9564-3778; OpenAlex author ID A5100666716. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- High-density lipoprotein-based nanoplatform reprograms tumor microenvironment and enhances chemotherapy against pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biomaterials.2025.123147↗
- Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal aden… Last author DOI 10.1038/s41392-024-02052-3↗
- Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter coh… Co-author DOI 10.18632/oncotarget.13000↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yukun Huang · 1 shared paper, 2025 · strength 0.27
- Jun Chen · 1 shared paper, 2025 · strength 0.27
- Zhouyu Ning · 2 shared papers, 2016–2024 · strength 0.22
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3↗
- Paper Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? … DOI 10.18632/oncotarget.13000↗
- Xiaoyan Zhu · 2 shared papers, 2016–2024 · strength 0.22
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3↗
- Paper Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? … DOI 10.18632/oncotarget.13000↗
- Zhiqiang Meng · 2 shared papers, 2016–2024 · strength 0.22
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3↗
- Paper Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? … DOI 10.18632/oncotarget.13000↗
- Lixia Yi · 1 shared paper, 2024 · strength 0.18
- Waimei Si · 1 shared paper, 2024 · strength 0.18
- Yifan Yang · 1 shared paper, 2024 · strength 0.18
- Yongqiang Hua · 1 shared paper, 2016 · strength 0.04
- Yehua Shen · 1 shared paper, 2016 · strength 0.04
- Lei Wang · 1 shared paper, 2016 · strength 0.04
- Lanyun Feng · 1 shared paper, 2016 · strength 0.04
- Chenyue Zhang · 1 shared paper, 2016 · strength 0.04
- Luming Liu · 1 shared paper, 2016 · strength 0.04
- Zhao‐Shen Li · 1 shared paper, 2016 · strength 0.04
- Zhen Chen · 1 shared paper, 2016 · strength 0.04
- Hao Chen · 1 shared paper, 2016 · strength 0.04
- Shu Dong Ma · 1 shared paper, 2016 · strength 0.04
- Yuanbiao Guo · 1 shared paper, 2016 · strength 0.04
- Jinming Yu · 1 shared paper, 2016 · strength 0.04
- Weidong Shi · 1 shared paper, 2016 · strength 0.04
- Qiwen Chen · 1 shared paper, 2016 · strength 0.04
- Lianyu Chen · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.